Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Natchaya Vanwong, Sayanit Tipnoppanon, Chalitpon Na Nakorn, Pornpen Srisawasdi, Punyanuch Rodcharoen, Sadeep Medhasi, Pajaree Chariyavilaskul, Sarawut Siwamogsatham, Yongkasem Vorasettakarnkij & Chonlaphat Sukasem. (2022) Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia. Pharmacogenomics and Personalized Medicine 15, pages 119-130.
Read now
Read now
Henrike Bruckmueller & Ingolf Cascorbi. (2021) ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?. Expert Opinion on Drug Metabolism & Toxicology 17:4, pages 369-396.
Read now
Read now
Punyabhorn Rattanacheeworn, Monpat Chamnanphon, Siriwan Thongthip, Wonngarm Kittanamongkolchai, Natavudh Townamchai, Yingyos Avihingsanon, Udomsak Udomnilobol, Thomayant Prueksaritanont, Suree Jianmongkol & Pajaree Chariyavilaskul. (2020) SLCO1B1 and ABCG2 Gene Polymorphisms in a Thai Population. Pharmacogenomics and Personalized Medicine 13, pages 521-530.
Read now
Read now
Articles from other publishers (17)
Alaa Yehya. 2023. Dosage Forms - Innovation and Future Perspectives. Dosage Forms - Innovation and Future Perspectives.
Aymen Shatnawi, Zourayz Kamran & Qusai Al-Share. (2023) Pharmacogenomics of lipid-lowering agents: the impact on efficacy and safety. Personalized Medicine 20:1, pages 65-86.
Crossref
Crossref
Chun-Hsien Su, Md. Mohaimenul Islam, Guhua Jia & Chieh-Chen Wu. (2022) Statins and the Risk of Gastric Cancer: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 11:23, pages 7180.
Crossref
Crossref
Serim Kim, Jong Do Seo, Yeo-Min Yun, Hanah Kim, Tae-Eun Kim, Taeheon Lee, Tae-Rim Lee, Jun Hyung Lee, Eun-Hae Cho & Chang-Seok Ki. (2022) Pharmacokinetics and Genetic Factors of Atorvastatin in Healthy Korean Subjects. Frontiers in Genetics 13.
Crossref
Crossref
Rommel G. Tirona & Richard B. Kim. 2022. Drug Transporters. Drug Transporters
79
113
.
Gabriel Stillemans, Adrien Paquot, Giulio G. Muccioli, Emilia Hoste, Nadtha Panin, Anders Åsberg, Jean‐Luc Balligand, Vincent Haufroid & Laure Elens. (2021) Atorvastatin population pharmacokinetics in a real‐life setting: Influence of genetic polymorphisms and association with clinical response. Clinical and Translational Science 15:3, pages 667-679.
Crossref
Crossref
Andrey Sivkov, Natalya Chernus, Roman Gorenkov, Sergey Sivkov, Svetlana Sivkova & Tamara Savina. (2021) Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia. Lipids in Health and Disease 20:1.
Crossref
Crossref
Jinhuan Dou, Angela Cánovas, Luiz F. Brito, Ying Yu, Flavio S. Schenkel & Yachun Wang. (2021) Comprehensive RNA-Seq Profiling Reveals Temporal and Tissue-Specific Changes in Gene Expression in Sprague–Dawley Rats as Response to Heat Stress Challenges. Frontiers in Genetics 12.
Crossref
Crossref
Song Gao, Edward C. Bell, Yun Zhang & Dong Liang. (2021) Racial Disparity in Drug Disposition in the Digestive Tract. International Journal of Molecular Sciences 22:3, pages 1038.
Crossref
Crossref
Hyoeun Kim, Chan Joo Lee, Hayeon Pak, Doo-Il Kim, Moo-Yong Rhee, Byoung Kwon Lee, Youngkeun Ahn, Byung-Ryul Cho, Jeong-Taek Woo, Seung-Ho Hur, Jin-Ok Jeong, Ji Hyun Lee & Sang-Hak Lee. (2020) GENetic characteristics and REsponse to lipid-lowering therapy in familial hypercholesterolemia: GENRE-FH study. Scientific Reports 10:1.
Crossref
Crossref
Ayaka Tajiri, Takeshi Hirota, Sasagu Kawano, Akira Yonamine & Ichiro Ieiri. (2020) Regulation of Organic Anion Transporting Polypeptide 2B1 Expression by MicroRNA in the Human Liver. Molecular Pharmaceutics 17:8, pages 2821-2830.
Crossref
Crossref
Perrine Courlet, Laurent A. Decosterd, Susana Alves Saldanha, Matthias Cavassini, Felix Stader, Marcel Stoeckle, Thierry Buclin, Catia Marzolini, Chantal Csajka & Monia Guidi. (2020) Influence of Drug–Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIV. Clinical Pharmacokinetics 59:8, pages 1037-1048.
Crossref
Crossref
Rafael B. R. León-Cachón, Aileen-Diane Bamford, Irene Meester, Hugo Alberto Barrera-Saldaña, Magdalena Gómez-Silva & María F. García Bustos. (2020) The atorvastatin metabolic phenotype shift is influenced by interaction of drug-transporter polymorphisms in Mexican population: results of a randomized trial. Scientific Reports 10:1.
Crossref
Crossref
Adriana H. Tremoulet, Sonia Jain, Pei-Ni Jone, Brookie M. Best, Elizabeth H. Duxbury, Alessandra Franco, Beth Printz, Samuel R. Dominguez, Heather Heizer, Marsha S. Anderson, Mary P. Glodé, Feng He, Robert L. Padilla, Chisato Shimizu, Emelia Bainto, Joan Pancheri, Harvey J. Cohen, John C. Whitin & Jane C. Burns. (2019) Phase I/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysm. The Journal of Pediatrics 215, pages 107-117.e12.
Crossref
Crossref
Bridget L. MorseJeffrey J. AlbertsMaria M. PosadaJessica RehmelAnil KolurLai San ThamCorina LoghinKathleen M. HillgrenStephen D. HallGemma L. Dickinson. (2019) Physiologically‐Based Pharmacokinetic Modeling of Atorvastatin Incorporating Delayed Gastric Emptying and Acid‐to‐Lactone Conversion. CPT: Pharmacometrics & Systems Pharmacology 8:9, pages 664-675.
Crossref
Crossref
Binbin Xia, Yali Li, Yatong Zhang, Ming Xue, Xiaorong Li, Pingxiang Xu, Tao Xia & Shicai Chen. (2018) UHPLC-MS/MS method for determination of atorvastatin calcium in human plasma: Application to a pharmacokinetic study based on healthy volunteers with specific genotype. Journal of Pharmaceutical and Biomedical Analysis 160, pages 428-435.
Crossref
Crossref
Marc Weiner, Jon Gelfond, Teresa L. Johnson-Pais, Melissa Engle, Charles A. Peloquin, John L. Johnson, Erin E. Sizemore & William R. Mac Kenzie. (2018)
Elevated Plasma Moxifloxacin Concentrations and
SLCO1B1
g.−11187G>A Polymorphism in Adults with Pulmonary Tuberculosis
. Antimicrobial Agents and Chemotherapy 62:5.
Crossref
Crossref